Skip to main navigation Skip to search Skip to main content

In Vitro Pharmacokinetic/Pharmacodynamics of LBH589 in Chronic Myelogenous Leukemia

Project: Research

Project Details

StatusFinished
Effective start/end date08/7/06 → 09/30/07

Funding

  • Novartis Pharmaceuticals Corporation: $94,406.00